AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MEDICA GROUP PLC

Remuneration Information Sep 17, 2019

4972_dirs_2019-09-17_eee45bf9-38ac-4173-af15-7ba28554ae14.html

Remuneration Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5088M

Medica Group PLC

17 September 2019

Medica Group PLC

Director / PDMR Shareholding

Medica Group PLC (the "Company") announces that on 16 September 2019, the PDMR listed below was granted options over ordinary shares of 0.2p each in the Company under the Company's Performance Share Plan 2017 at a nil exercise price:

Name of PDMR Number of shares subject to option
Dr Stuart Quin 533,682

The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation and set out more details of the transactions.

1. Details of PDMR
(a) Name 1.           Dr Stuart Quin
2. Reason for notification
(b) Position / status 1.           Chief Executive Officer
(c) Initial notification / amendment Initial notification in each case
3. Details of the Issuer
(a) Name Medica Group PLC
(b) LEI
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted
(a) Description of the financial instrument Ordinary shares of 0.2p each in the capital of the Company ("Shares")
(b) Nature of the transaction Grant of options to acquire Shares pursuant to the Company's Performance Share Plan 2017
(c) Price(s) and volume Exercise Price nil
(d) Aggregated information N/A
(e) Date of the transaction 16 September 2019
(f) Place of the transaction Outside a trading venue

-ENDS-

For further details contact:

Medica Group: +44 (0)33 33 111 222
Stuart Quin, Chief Executive Officer
Tony Lee, Chief Financial Officer
FTI Consulting +44 (0)20 3727 1000
Brett Pollard
Victoria Foster Mitchell
Robert Winder

About Medica

Medica is the UK market leader by revenue in the provision of teleradiology services, providing outsourced interpretation and reporting on MRI (magnetic resonance imaging), CT (computerised tomography) and plain film (x-ray) images. The Company currently offers three primary services to hospital radiology departments: NightHawk, an out-of-hours service, routine cross-sectional (Routine CS) reporting on MRI and CT scans, and routine plain film (Routine PF) reporting on x-ray images.

Medica has developed a bespoke secure IT platform that provides market-leading linkage between a hospital's Radiology Information System (RIS) and Consultant Radiologists who contract with Medica. Direct RIS access ensures that the full wider patient information is available and reviewed with every report. 

The Company contracts with the largest pool of consultant radiologists outside of the NHS and has been trusted to provide more than 1.5 million examinations annually across its customer base of more than 100 NHS hospitals and various private hospital groups and diagnostic imaging companies. For more information please visit www.medicagroup.co.uk 

About teleradiology

Teleradiology is the electronic transmission of radiological patient images, including plain film (x-rays), CT scans and MRI scans, from one location to another for the purposes of diagnostic interpretation and reporting.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHCKADPPBKDDCD

Talk to a Data Expert

Have a question? We'll get back to you promptly.